Pay in 4 interest-free payments of $7.46 Learn more
Ships within 48 hours · Estimated delivery Aug 11 - Aug 16
Ongoing support, regular follow-ups, and realistic expectations are key to achieving the best possible outcomes
Tirzepatide: 20.2% in SURMOUNT-5 In the head-to-head SURMOUNT-5 trial, tirzepatide reached 20.2% average weight loss compared with 13.7% for semaglutide at 72 weeks
Stick with brand-name products from known manufacturers like Novo Nordisk (semaglutide) and Eli Lilly (tirzepatide)
The app calculates personalized protein targets based on your current weight and goals, then prompts you to log intake throughout the day
Increased risk of hypoglycemia when combined with other medicines causing low blood sugar such as sulfonylurea or insulin
US$ 20.29
US$ 26.18
US$ 20.71
US$ 24.05
US$ 28.11
US$ 24.74
US$ 22.42
